Investors

Events and Presentations

Analyst Coverage

Corporate Governance

Investor Contacts & Alerts

News Releases

Jun 2, 2020

Evofem Announces Proposed Public Offering of Common Stock
May 22, 2020

U.S. FDA Approves Evofem Biosciences' Phexxi™ (lactic acid, citric acid and potassium bitartrate), the First and Only Non-Hormonal Prescription Gel for the Prevention of Pregnancy

- A New Class of Female-Controlled Birth Control for Use In-The-Moment -
May 13, 2020

Evofem Biosciences to Participate in Virtual Fireside Chat at RBC Capital Markets Global Healthcare Conference
May 6, 2020

Evofem Biosciences Reports First Quarter 2020 Financial Results and Provides Corporate Update

- On-Track for Phexxi™ PDUFA Date: May 25, 2020 -
May 1, 2020

Evofem Biosciences Announces New Location and COVID-19 Preventative Measures for 2020 Annual Meeting Scheduled for May 12, 2020

Show per page